---
title: "12 Health Care Stocks Moving In Tuesday's Pre-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284382152.md"
description: "In Tuesday's pre-market session, several health care stocks experienced significant movements. Notable gainers included Pomdoctor (POM) with a 30.4% rise to $0.39, Omnicell (OMCL) up 23.3% to $46.4, and Axogen (AXGN) increasing by 12.97% to $44.5. Conversely, Soligenix (SNGX) saw a sharp decline of 51.7% to $0.68, while Erasca (ERAS) fell 43.29% to $10.86. Other notable losers included iTonic Holdings (ITOC) down 13.34% and HCW Biologics (HCWB) down 12.62%."
datetime: "2026-04-28T12:05:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284382152.md)
  - [en](https://longbridge.com/en/news/284382152.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284382152.md)
---

# 12 Health Care Stocks Moving In Tuesday's Pre-Market Session

### Gainers

-   **Pomdoctor** (NASDAQ:POM) shares rose 30.4% to $0.39 during Tuesday's pre-market session. The market value of their outstanding shares is at $36.0 million.
-   **Omnicell** (NASDAQ:OMCL) stock moved upwards by 23.3% to $46.4. The market value of their outstanding shares is at $1.7 billion. As per the press release, Q1 earnings came out today.
-   **Axogen** (NASDAQ:AXGN) shares rose 12.97% to $44.5. The company's market cap stands at $1.9 billion. As per the news, the Q1 earnings report came out today.
-   **SenesTech** (NASDAQ:SNES) stock moved upwards by 12.43% to $1.66. The company's market cap stands at $7.8 million.
-   **Calidi Biotherapeutics** (AMEX:CLDI) stock increased by 11.45% to $0.26. The company's market cap stands at $2.2 million.
-   **Kiniksa Pharmaceuticals** (NASDAQ:KNSA) stock rose 9.93% to $47.94. The market value of their outstanding shares is at $3.3 billion. As per the press release, Q1 earnings came out today.

### Losers

-   **Soligenix** (NASDAQ:SNGX) stock decreased by 51.7% to $0.68 during Tuesday's pre-market session. The market value of their outstanding shares is at $14.2 million.
-   **Erasca** (NASDAQ:ERAS) stock fell 43.29% to $10.86. The company's market cap stands at $5.9 billion.
-   **iTonic Holdings** (NASDAQ:ITOC) stock fell 13.34% to $0.35. The company's market cap stands at $6.9 million.
-   **HCW Biologics** (NASDAQ:HCWB) shares decreased by 12.62% to $0.38. The market value of their outstanding shares is at $2.9 million.
-   **SciSparc** (NASDAQ:SPRC) stock decreased by 11.23% to $7.75. The company's market cap stands at $4.9 million.
-   **Aditxt** (NASDAQ:ADTX) shares declined by 8.84% to $0.23. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [POM.US](https://longbridge.com/en/quote/POM.US.md)
- [HCWB.US](https://longbridge.com/en/quote/HCWB.US.md)
- [AXGN.US](https://longbridge.com/en/quote/AXGN.US.md)
- [ERAS.US](https://longbridge.com/en/quote/ERAS.US.md)
- [SNGX.US](https://longbridge.com/en/quote/SNGX.US.md)
- [OMCL.US](https://longbridge.com/en/quote/OMCL.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [SNES.US](https://longbridge.com/en/quote/SNES.US.md)
- [CLDI.US](https://longbridge.com/en/quote/CLDI.US.md)
- [KNSA.US](https://longbridge.com/en/quote/KNSA.US.md)
- [ITOC.US](https://longbridge.com/en/quote/ITOC.US.md)
- [SPRC.US](https://longbridge.com/en/quote/SPRC.US.md)
- [ADTX.US](https://longbridge.com/en/quote/ADTX.US.md)

## Related News & Research

- [Erasca Touts 'Eye-Popping' ERAS-0015 Lung Cancer Data, FDA Path at BofA Conference](https://longbridge.com/en/news/286652404.md)
- [HCW Biologics Q1 revenue surges on licensing deal](https://longbridge.com/en/news/286464528.md)
- [POMDOCTOR LIMITED Announces Fiscal Year 2025 Financial Results | POM Stock News](https://longbridge.com/en/news/286463818.md)
- [Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/286497683.md)
- [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)